FDA approves Emergent vaccine for mpox as company plans to donate 50,000 doses

Katherine Lewin

News Reporter

Emergent BioSolutions scored an expanded FDA approval for its single-dose vaccine, ACAM2000, to now include the prevention of mpox disease in people at high risk …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA approves Emergent vaccine for mpox as company plans to donate 50,000 doses

Katherine Lewin

News Reporter

Sign up to read this article for free.

SEC probe of Illumina’s Grail deal targets sales forecasts, sources say

Exclusive: A male contraceptive may prevent 99% of pregnancies. Now it’s up to a small biotech to finish testing it

House passes Biosecure Act, sending Chinese biotech ban to Senate

GSK, iTeos rejuvenate struggling TIGIT space with positive Phase 2 Jemperli combo data in lung cancer

#ESMO24 roundup: New data on Amgen’s PRMT5 inhibitor seem lackluster, and Jazz’s HER2 antibody

Adcomm says Intercept's rare liver disease drug should not get full approval

FDA ap­proves Emer­gent vac­cine for mpox as com­pa­ny plans to do­nate 50,000 dos­es

Katherine Lewin

News Reporter

Sign up to read this article for free.

more like this

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

Ex­clu­sive: A male con­tra­cep­tive may pre­vent 99% of preg­nan­cies. Now it’s up to a small biotech to fin­ish test­ing it

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

GSK, iTeos re­ju­ve­nate strug­gling TIG­IT space with pos­i­tive Phase 2 Jem­per­li com­bo da­ta in lung can­cer

#ES­MO24 roundup: New da­ta on Am­gen’s PRMT5 in­hibitor seem lack­lus­ter, and Jazz’s HER2 an­ti­body

Ad­comm says In­ter­cep­t's rare liv­er dis­ease drug should not get full ap­proval

FDA approves Emergent vaccine for mpox as company plans to donate 50,000 doses

SEC probe of Illumina’s Grail deal targets sales forecasts, sources say

Exclusive: A male contraceptive may prevent 99% of pregnancies. Now it’s up to a small biotech to finish testing it

House passes Biosecure Act, sending Chinese biotech ban to Senate

GSK, iTeos rejuvenate struggling TIGIT space with positive Phase 2 Jemperli combo data in lung cancer

#ESMO24 roundup: New data on Amgen’s PRMT5 inhibitor seem lackluster, and Jazz’s HER2 antibody

Adcomm says Intercept's rare liver disease drug should not get full approval